Immunome Inc
NASDAQ:IMNM
Immunome Inc
NASDAQ:IMNM
Price:
23.67
USD
-5.05%
Market Closed
Market Cap:
$2.2B
Balance Sheet
Balance Sheet Decomposition
Immunome Inc
Immunome Inc
Balance Sheet Decomposition is not available for
Immunome Inc
Immunome Inc
Balance Sheet
Immunome Inc
Immunome Inc
Currency: USD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
2
|
3
|
40
|
49
|
20
|
99
|
143
|
|
| Cash |
2
|
3
|
40
|
49
|
20
|
99
|
143
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
39
|
74
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Other Current Assets |
1
|
1
|
3
|
7
|
1
|
7
|
4
|
|
| Total Current Assets |
2
|
3
|
43
|
57
|
23
|
145
|
221
|
|
| PP&E Net |
2
|
2
|
2
|
1
|
1
|
4
|
14
|
|
| PP&E Gross |
2
|
2
|
2
|
1
|
1
|
4
|
14
|
|
| Accumulated Depreciation |
1
|
2
|
2
|
3
|
3
|
4
|
5
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
5
|
|
| Total Assets |
4
N/A
|
5
+14%
|
45
+780%
|
58
+30%
|
24
-58%
|
149
+518%
|
240
+62%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
1
|
1
|
3
|
2
|
3
|
14
|
|
| Accrued Liabilities |
0
|
1
|
1
|
7
|
5
|
8
|
31
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
11
|
9
|
|
| Total Current Liabilities |
2
|
2
|
3
|
10
|
7
|
22
|
54
|
|
| Long-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
7
|
5
|
|
| Total Liabilities |
2
N/A
|
2
-16%
|
3
+77%
|
10
+206%
|
7
-24%
|
29
+288%
|
59
+106%
|
|
| Equity | ||||||||
| Common Stock |
28
|
39
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
26
|
37
|
54
|
79
|
116
|
223
|
516
|
|
| Additional Paid In Capital |
1
|
1
|
96
|
127
|
133
|
343
|
697
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
2
N/A
|
3
+41%
|
41
+1 168%
|
48
+17%
|
17
-65%
|
120
+620%
|
181
+51%
|
|
| Total Liabilities & Equity |
4
N/A
|
5
+14%
|
45
+780%
|
58
+30%
|
24
-58%
|
149
+518%
|
240
+62%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
9
|
9
|
11
|
12
|
12
|
43
|
64
|
|
Switch to:
Switch to:
See Also
Discover More
